EAVA Virtual Activities
Wave 3
Biomarkers in Heart Failure: Current Status and Future Prospects.
Ashraf Reda
Diastolic heart failure: From pathophysiology to therapy
Nabil Farag
Wave 4
Coagulopathy and systemic
thrombosis in COVID-19 disease
Ashraf Reda
protecting AF patients with
Diabetes
Mohamed Seleem
Wave 5
Key messages of dyslipidemia guidelines: Egyptian prospects
Ashraf Reda
Dyslipidemia Case Discussion
Ahmed Shawky
Wave 6
Update in Hypertension Guidelines: Focus on
RAAS inhibition and COVID-19
Ashraf Reda
Case discussion: Management of the high risk hypertensive patient
Ahmed Shawky
Wave 7
Remnant Cholesterol, Triglycerides and Residual Risk
Ashraf Reda
Triglycerides and Non – HDL-c in the guidelines
Nabil Farag
Lipid Case
Ahmed Shawky
EAVA Lipid Summit
The Inflammatory theory of Atherosclerosis
Andreas Zirilik
It is not only LDL-C The
role of triglycerides-Rich lipoproteins
Ashraf Reda
PCSK9- I in the
guidelines
Dirk Von Lewinski